These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18078748)

  • 1. Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists.
    Liu XW; Ma J; Colson AO; Doersen DC; Ebetino FH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1223-8. PubMed ID: 18078748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists.
    Tian X; Chen X; Gan L; Hayes JC; Switzer AG; Solinsky MG; Ebetino FH; Wos JA; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1721-5. PubMed ID: 16376076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
    Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism.
    Simon S; Young TJ; Nickolls SA
    Eur J Pharmacol; 2009 Aug; 615(1-3):33-9. PubMed ID: 19446549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists.
    Bakshi RK; Hong Q; Olson JT; Ye Z; Sebhat IK; Weinberg DH; MacNeil T; Kalyani RN; Tang R; Martin WJ; Strack A; McGowan E; Tamvakopoulos C; Miller RR; Stearns RA; Tang W; Maclntyre DE; van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3430-3. PubMed ID: 15951175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
    Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
    Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.
    Szewczyk JR; Laudeman CP; Sammond DM; Villeneuve M; Minick DJ; Grizzle MK; Daniels AJ; Andrews JL; Ignar DM
    Bioorg Med Chem; 2010 Mar; 18(5):1822-33. PubMed ID: 20172734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold.
    Yan LZ; Flora D; Edwards P; Smiley DL; Emmerson PJ; Hsiung HM; Gadski R; Hertel J; Heiman ML; Husain S; O'Brien TP; Kahl SD; Zhang L; Dimarchi RD; Mayer JP
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4611-4. PubMed ID: 16105738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors.
    Alam MS; Huang J; Ozoe F; Matsumura F; Ozoe Y
    Bioorg Med Chem; 2007 Aug; 15(15):5090-104. PubMed ID: 17544280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors.
    Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y
    Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity.
    He S; Ye Z; Dobbelaar PH; Bakshi RK; Hong Q; Dellureficio JP; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Reibarkh M; Holmes MA; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6524-32. PubMed ID: 20933410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation.
    Hogan K; Peluso S; Gould S; Parsons I; Ryan D; Wu L; Visiers I
    J Med Chem; 2006 Feb; 49(3):911-22. PubMed ID: 16451057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.
    Hess S; Linde Y; Ovadia O; Safrai E; Shalev DE; Swed A; Halbfinger E; Lapidot T; Winkler I; Gabinet Y; Faier A; Yarden D; Xiang Z; Portillo FP; Haskell-Luevano C; Gilon C; Hoffman A
    J Med Chem; 2008 Feb; 51(4):1026-34. PubMed ID: 18220330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
    Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
    Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.